The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE)
The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE)
New York, New York, United States5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fareon Open Label Device Clinical Trial | Alzheimer disease, Brain Injuries, Traumatic, COVID-19, Chronic Disease, Cognition Disorders, Cognitive Dysfunction, Coronaviridae Infections, Craniocerebral Trauma, Disease Attributes, Infections, Neuroinflammatory Diseases, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, brain disorder, brain injury, central nervous system disorder, cognitive disorder, dementia, encephalomyelitis, injury, long COVID-19, lung disorder, muscle tissue disorder, musculoskeletal system disorder, myalgic encephalomeyelitis/chronic fatigue syndrome, nervous system disorder, nervous system injury, neurodegenerative disease, neuromuscular disease, pneumonia, psychiatric disorder, respiratory system disorder, respiratory tract infectious disorder, tauopathy, viral infectious disease, viral pneumonia | Not yet recruiting | Not applicable | 2026-05-20 | NCT07600320 | |
| SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, long COVID-19, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Not yet recruiting | Phase 2 | 2026-05-19 | NCT07597902 | |
| Sana Device for Post-Treatment Lyme Disease Syndrome Chronic Pain | Bacterial Infections and Mycoses, Borrelia infectious disease, Chronic Disease, Chronic Pain, Disease Attributes, Infections, Lyme disease, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, Signs and Symptoms, bacterial infectious disease, gram-negative bacterial infections, post-treatment Lyme disease syndrome, spirochaetales infections, tick-borne infectious disease, vector-borne disease | Recruiting | Not applicable | 2026-05-18 | NCT06655844 | |
| Antiviral Clinical Trial for Long Covid-19 | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, long COVID-19, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 2 | 2026-03-13 | NCT06511063 | |
| Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | Bacterial Infections and Mycoses, Borrelia infectious disease, COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Lyme disease, Neuroinflammatory Diseases, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, bacterial infectious disease, encephalomyelitis, gram-negative bacterial infections, long COVID-19, lung disorder, muscle tissue disorder, musculoskeletal system disorder, myalgic encephalomeyelitis/chronic fatigue syndrome, nervous system disorder, neuromuscular disease, pneumonia, post-treatment Lyme disease syndrome, respiratory system disorder, respiratory tract infectious disorder, spirochaetales infections, tick-borne infectious disease, vector-borne disease, viral infectious disease, viral pneumonia | Recruiting | Phase 1 / Phase 2 | 2026-03-13 | NCT06511050 |